Entropy Technologies’s Transmedics TMDX Stock Holding History

Entropy Technologies’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,742	Closed	-$455K	–	1159
2025 Q4	$455K	Buy	+3,742	New	+$470K	0.02%	589
2024 Q4	–	Sell	-10,471	Closed	-$1.64M	–	994
2024 Q3	$1.64M	Buy	10,471 +2,700	+35%	+$416K	0.17%	177
2024 Q2	$1.17M	Buy	7,771 +5,056	+186%	+$606K	0.13%	212
2024 Q1	$201K	Buy	+2,715	New	+$224K	0.02%	655

Other funds holding TMDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Entropy Technologies's TMDX Position: Q1 2026 in Review

Entropy Technologies sold out of Transmedics (TMDX) in Q1 2026, closing a stake of 3,742 shares — an estimated $455K sold.

Entropy Technologies first reported a position in TMDX in Q1 2024 and held it in 4 quarters. The position peaked at $1.64M in Q3 2024. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

Entropy Technologies reported no remaining Transmedics position as of Q1 2026 after selling out during the quarter.
Entropy Technologies sold 3,742 Transmedics shares in Q1 2026, an estimated $455K.
Entropy Technologies first reported a position in Transmedics in Q1 2024 and held it in 4 quarters.
Entropy Technologies's Transmedics position peaked at $1.64M in Q3 2024.
414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Entropy Technologies's 13F filing for Q1 2026, filed 14 May 2026.